Skip to main content
. Author manuscript; available in PMC: 2013 Jan 27.
Published in final edited form as: Immunity. 2011 Dec 28;36(1):68–78. doi: 10.1016/j.immuni.2011.12.007

Figure 7. Mitochondrial FAO enhances T cell survival and promotes CD8+ TM cell development.

Figure 7

OVA peptide activated OT-I cells transduced with control (empty vector) or CPT1a expressing (EX) retrovirus were intravenously injected into congenic recipients (n = 5 per group), and (A) organs were harvested 2 days later, dot plots show percentages (top panels), or total numbers (bottom panels) of donor cells (mean ± SEM); *P < 0.0001 (top left), < 0.0001 (top right), 0.03 (bottom left), and 0.0006 (bottom right), or (B) mice were infected with LmOVA, and peripheral blood CD8+ T cells were analyzed by KbOVA tetramer (line graphs) and GFP for retroviral expression (contour plots) at the peak of the response (TE cells, day 7) and after contraction (TM cells, day 14). Contour plots and bar graphs show the frequency of transduced (GFP+) cells within the CD8+ and KbOVA tetramer positive gate in blood (left bar graph; *P = 0.0003), absolute numbers of transduced (GFP+) cells/ml blood (middle bar graph, data are normalized to control TE cells; P = 0.02, numbers above bars indicate fold contraction), and absolute numbers of transduced (GFP+) cell in spleen (right bar graph, data are normalized to control TE cells). Data are shown as mean ± SEM and are representative of at least 2 independent experiments with at least 5 mice per group. (C) OT-I cells transduced with control (empty vector) or CPT1a expressing (EX) retrovirus were intravenously injected into IL-15 deficient recipients (n = 5 per group) and mice were infected with LmOVA. Bar graphs show the frequency of transduced (GFP+) cells within the KbOVA tetramer gate at the peak of the response (TE cells, day 7), after contraction (TM cells, day 14) and after challenge (recall, day 5 post challenge); *P = 0.01. Data are shown as mean ± SEM and are representative of 2 independent experiments. See also Figure S6.